Clinical Trial Update: Civamide Nasal Solution for Postherpetic Neuralgia of the Trigeminal Nerve [Phase 2]

View source ↗

Summary

A Phase 2 trial of Civamide Nasal Solution for postherpetic neuralgia of the trigeminal nerve was terminated, and the study results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• Civamide Nasal Solution (civamide)

Snippet

Sponsor: Winston Laboratories | Conditions: Postherpetic Neuralgia | Phase 2 | Status: TERMINATED | Results posted: 2017-03-01